Tango Therapeutics, Inc. ( TNGX) - Key Metrics
TNGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.33 | -$0.26 | -$0.26 |
| 2025Q3 | $0.48 | $0.14 | -$0.28 | -$0.28 |
| 2025Q2 | $0.03 | -$0.35 | -$0.33 | -$0.34 |
| 2025Q1 | $0.05 | -$0.36 | -$0.38 | -$0.38 |
TNGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.64 |
| 2025Q3 | ? | 14.67 |
| 2025Q2 | ? | -3.64 |
| 2025Q1 | ? | -0.95 |
TNGX
Price: $32.90
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179400
Market Capitalization: 2.6 billion